Y. Xu

First name
Y.
Last name
Xu
Wilkinson, A. J. K., Maslova, E. ., Janson, C. ., Radhakrishnan, V. ., Quint, J. K., Budgen, N. ., … Bell, J. P. (2024). Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study. Thorax. http://doi.org/10.1136/thorax-2023-220259
Attar-Zadeh, D. ., Capstick, T. ., Leese, D. ., Arnetorp, S. ., Rapsomaniki, E. ., Da Costa, K. P., … Quint, J. K. (2023). Healthcare costs associated with short-acting β(2)-agonists in asthma: observational UK SABINA study. BJGP Open. http://doi.org/10.3399/bjgpo.2023.0015
Whittaker, H. ., Nordon, C. ., Rubino, A. ., Morris, T. ., Xu, Y. ., de Nigris, E. ., … Quint, J. K. (2022). Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study. Thorax. http://doi.org/10.1136/thorax-2022-219039
Whittaker, H. ., Rubino, A. ., Mullerova, H. ., Morris, T. ., Varghese, P. ., Xu, Y. ., … Quint, J. K. (2022). Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study. Int J Chron Obstruct Pulmon Dis, 17, 427–437. http://doi.org/10.2147/copd.s346591
Hoffman, V. ., Hallas, J. ., Linder, M. ., Margulis, A. V., Suehs, B. T., Arana, A. ., … Seeger, J. D. (2021). Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study. Drug Saf. http://doi.org/10.1007/s40264-021-01095-7